📣 VC round data is live. Check it out!
- Public Comps
- Medicover
Medicover Valuation Multiples
Discover Medicover's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Asker Healthcare Group, Mouwasat, Global Health, Meinian Onehealth and more.
Medicover Overview
About Medicover
Medicover AB is an international healthcare and diagnostic services, provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. The company offers its services through two segments; Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas in Germany, Romania, Poland, and Ukraine; and Healthcare Services offer high-quality care based on an Integrated Healthcare Model and Fee-For-Service in Poland, India, and Romania. It generates maximum revenue from the Healthcare Services segment. Geographically, it derives a majority of its revenue from Poland and also has a presence in Romania; Germany; Ukraine; India, and Other Countries.
Founded
1995
HQ

Employees
47.3K
Website
Sectors
Financials (LTM)
EV
$5B
Valuation Multiples
Start free trialMedicover Financials
Medicover reported last 12-month revenue of $3B and EBITDA of $477M.
In the same LTM period, Medicover generated $664M in gross profit, $477M in EBITDA, and $100M in net income.
Revenue (LTM)
Medicover P&L
In the most recent fiscal year, Medicover reported revenue of $3B and EBITDA of $456M.
Medicover is profitable as of last fiscal year, with gross margin of 23%, EBITDA margin of 16%, and net margin of 3%.
Financial data powered by Morningstar, Inc.
Medicover Stock Performance
Medicover has current market cap of $3B, and enterprise value of $5B.
Market Cap Evolution
Medicover's stock price is $22.62.
Medicover share price decreased by 0.8% in the last 30 days, and by 16.8% in the last year.
Medicover has an EPS (earnings per share) of $0.60.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5B | $3B | -0.8% | -0.8% | 10.0% | -16.8% | $0.60 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMedicover Valuation Multiples
Medicover trades at 1.7x EV/Revenue multiple, and 10.4x EV/EBITDA.
EV / Revenue (LTM)
Medicover Financial Valuation Multiples
As of June 2, 2026, Medicover has market cap of $3B and EV of $5B.
Medicover has a P/E ratio of 34.0x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Medicover Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Medicover Margins & Growth Rates
Medicover grew revenue by 8% and EBITDA by 11% in the last fiscal year.
In the most recent fiscal year, Medicover reported gross margin of 23%, EBITDA margin of 16%, and net margin of 3%.
Medicover Margins
Medicover Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Medicover Operational KPIs
Medicover's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Medicover's Rule of 40 is 27% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Medicover's Rule of X is 42% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Medicover Competitors
Medicover competitors include Asker Healthcare Group, Mouwasat, Global Health, Meinian Onehealth, Kpj Healthcare, Concentra Group, Option Care Health, Krishna Institute, LifeStance Health and Aster DM Healthcare.
Most Medicover public comparables operate across Hospitals & Clinics.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 2.1x | 2.0x | 17.6x | 16.7x | |||
| 4.2x | 4.0x | 11.9x | 12.0x | |||
| 7.1x | 7.0x | 30.9x | 32.8x | |||
| 2.5x | 2.4x | 11.8x | 13.2x | |||
| 3.9x | 3.8x | 16.0x | 16.1x | |||
| 2.4x | 2.4x | 12.3x | 11.8x | |||
| 0.8x | 0.8x | 9.1x | 9.1x | |||
| 8.8x | 8.4x | 41.8x | 40.5x | |||
This data is available for Pro users. Sign up to see all Medicover competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Medicover
Medicover has acquired 6 companies to date.
Last acquisition by Medicover was on June 2nd 2022. Medicover acquired MeinDentist for undisclosed valuation.
Latest Acquisitions by Medicover
| Description | - | Polaris Medical is a Timișoara-based clinic in Romania offering gastroenterology, obstetrics, gynecology, oncology, pneumology, pediatrics, and internal medicine consultations. The facility provides diagnostic imaging, endoscopy, and surgical procedures. | NIPD Genetics is a Nicosia-based molecular diagnostics firm focused on non-invasive prenatal testing through cell-free fetal DNA analysis. The company offers the Genera test suite for detecting chromosomal abnormalities such as trisomies 21, 18, and 13, along with sex chromosome aneuploidies and microdeletions. Established in 2010, NIPD Genetics launched one of the first commercial non-invasive prenatal tests in Europe in 2013. Its laboratory holds ISO 15189 accreditation and serves clinics across Cyprus, Greece, the Middle East, and beyond. | NEOMEDIC is a Poland-based hospital group operating obstetric-gynecology facilities in Kraków and Nowy Sącz delivering 7,000 babies annually. The network provides neonatology, maternity, and IVF services with Level III NICUs equipped for preterm care. NEOMEDIC integrates telehealth for prenatal consultations across southern Poland. | |
| HQ Country | |||||
| HQ City | - | Suceava | Nicosia | Krakow | |
| Deal Date | 2 Jun 2022 | 13 Jan 2022 | 9 Dec 2021 | 15 Feb 2019 | |
| Valuation | undisclosed | undisclosed | $103M | $76M | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Medicover acquisitions and their M&A valuation multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Medicover
| When was Medicover founded? | Medicover was founded in 1995. |
| Where is Medicover headquartered? | Medicover is headquartered in Sweden. |
| How many employees does Medicover have? | As of today, Medicover has over 47K employees. |
| Who is the CEO of Medicover? | Medicover's CEO is Fredrik Ragmark. |
| Is Medicover publicly listed? | Yes, Medicover is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Medicover? | Medicover trades under MCOV B ticker. |
| When did Medicover go public? | Medicover went public in 2017. |
| Who are competitors of Medicover? | Medicover main competitors include Asker Healthcare Group, Mouwasat, Global Health, Meinian Onehealth, Kpj Healthcare, Concentra Group, Option Care Health, Krishna Institute, LifeStance Health, Aster DM Healthcare. |
| What is the current market cap of Medicover? | Medicover's current market cap is $3B. |
| What is the current revenue of Medicover? | Medicover's last 12 months revenue is $3B. |
| What is the current revenue growth of Medicover? | Medicover revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of Medicover? | Current revenue multiple of Medicover is 1.7x. |
| What is the current EBITDA of Medicover? | Medicover's last 12 months EBITDA is $477M. |
| What is Medicover's EBITDA margin? | Medicover's last 12 months EBITDA margin is 16%. |
| What is the current EV/EBITDA multiple of Medicover? | Current EBITDA multiple of Medicover is 10.4x. |
| What is the current FCF of Medicover? | Medicover's last 12 months FCF is $71M. |
| What is Medicover's FCF margin? | Medicover's last 12 months FCF margin is 2%. |
| What is the current EV/FCF multiple of Medicover? | Current FCF multiple of Medicover is 70.1x. |
| How many companies Medicover has acquired to date? | As of June 2026, Medicover has acquired 6 companies. |
| What was the largest acquisition by Medicover? | $103M acquisition of NIPD Genetics on 9th December 2021 was the largest M&A Medicover has done to date. |
| What companies Medicover acquired? | Medicover acquired NIPD Genetics, NEOMEDIC, Spitalul Pelican, OK System Polska SA, MeinDentist, and Polaris Medical. |
| In how many companies Medicover has invested to date? | Medicover hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Medicover
Lists including Medicover
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.



